Interview: Dr. Volker Wendel, Sanoptis

Dr. Volker Wendel founded Sanoptis in 2018 in Switzerland with Carsten Horn. Six years later, the group has grown to more than 400 locations across six European countries. The group was initially backed by PE firm Telemos Capital, who then sold it to Belgian holding company Group Bruxelles Lambert (in 2022). Wendel explains to us how the group is able to add value to ophthalmologists who join the network and shares which areas the group will be focusing on in the coming years.

Top 5 European ophthalmology players

This infographic showcases Europe's top 5 ophthalmology players by revenue in the reporting period 2018–2022: Veonet Group, Sanoptis, Artemis Augenkliniken, Clinica Baviera, and Optegra.

Big Greek exits rumoured, despite strong market

Rumours of a big hospital sell-off have started circulating in Greece, with Farallon (formally main creditor of and now main shareholder in Euromedica) and Luxembourg-based PE firm CVC (Hellenic Healthcare Group hospitals) both potentially looking to exit. The moves could trigger a wave of deals.

Henry Dunant to take over Euromedica, not merge with it

Hemithea (formerly Imithea), the parent company of Greece’s largest private hospital Henry Dunant, is set to take over the secondary care activities of healthcare group Euromedica, as opposed to merging with it, among a flurry of possible Greek hospital sales.

Diaverum enters Greece, and plans expansion

Multinational dialysis giant Diaverum has entered the Greek market with the acquisition of six clinics. HBI hears the group has plans to consolidate more of the market and become the country’s best quality provider.

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.

HBI 2023: The outpatient differential

For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.

Diagnostic groups to take on the Greek government

The big Greek for-profit health care groups are forming a national association to take on the Greek government which continues after a decade to claw back yearly a percentage of their profits. Meanwhile an investor tells us that the French government is worried there may be similar moves in France where labs are seeking to negotiate a new three-year price deal.

Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.

Henry Dunant-Euromedica merger unlikely to sell for three years

The company formed as a result of the merger between Euromedica and Imithea, the parent company of Henry Dunant, Greece’s largest private hospital, is unlikely to sell for three years, HBI hears. Click here to read our reports on the for-profit hospital sector, and here to read more about Euromedica, and here to read more […]

Find Us